Matches in Wikidata for { <http://www.wikidata.org/entity/Q93012916> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q93012916 description "2019 ആഗസ്റ്റ് 27 നു പ്രസിദ്ധീകരിച്ച ശാസ്ത്ര ലേഖനം" @default.
- Q93012916 description "article scientifique publié en 2019" @default.
- Q93012916 description "artículu científicu espublizáu n'agostu de 2019" @default.
- Q93012916 description "scientific article published on 27 August 2019" @default.
- Q93012916 description "wetenschappelijk artikel" @default.
- Q93012916 description "наукова стаття, опублікована 27 серпня 2019" @default.
- Q93012916 description "գիտական հոդված հրատարակված 2019 թվականի օգոստոսի 27-ին" @default.
- Q93012916 name "Validated animal models for antiseizure drug (ASD) discovery: Advantages and potential pitfalls in ASD screening" @default.
- Q93012916 name "Validated animal models for antiseizure drug (ASD) discovery: Advantages and potential pitfalls in ASD screening" @default.
- Q93012916 type Item @default.
- Q93012916 label "Validated animal models for antiseizure drug (ASD) discovery: Advantages and potential pitfalls in ASD screening" @default.
- Q93012916 label "Validated animal models for antiseizure drug (ASD) discovery: Advantages and potential pitfalls in ASD screening" @default.
- Q93012916 prefLabel "Validated animal models for antiseizure drug (ASD) discovery: Advantages and potential pitfalls in ASD screening" @default.
- Q93012916 prefLabel "Validated animal models for antiseizure drug (ASD) discovery: Advantages and potential pitfalls in ASD screening" @default.
- Q93012916 P1433 Q93012916-C4292847-F505-4D86-8912-E82500B8C0C4 @default.
- Q93012916 P1476 Q93012916-E8D58F26-D4F7-437B-9733-06B4F6EC2D00 @default.
- Q93012916 P2093 Q93012916-6CBC089B-7EC4-4F64-A415-D8961107C8B0 @default.
- Q93012916 P2093 Q93012916-F71D9357-1025-449B-AD50-B51000C1666E @default.
- Q93012916 P304 Q93012916-97BF7DEB-50A8-40C2-8E2F-93762EEF2CD4 @default.
- Q93012916 P31 Q93012916-1bff8c46-ffb0-433c-b882-b2e4d5b13a91 @default.
- Q93012916 P31 Q93012916-798EB99E-3338-46CB-A4EC-06A03D0FE711 @default.
- Q93012916 P356 Q93012916-F02F904E-5421-4404-997F-83660EF86437 @default.
- Q93012916 P478 Q93012916-BA849DB6-45C1-44D9-BD69-A5206177AA9A @default.
- Q93012916 P577 Q93012916-5BCE75FD-978F-4919-B792-2EA369EEE916 @default.
- Q93012916 P698 Q93012916-5BF84606-4495-4155-A5B1-229F87BE7C25 @default.
- Q93012916 P356 J.NEUROPHARM.2019.107750 @default.
- Q93012916 P698 31469995 @default.
- Q93012916 P1433 Q15332439 @default.
- Q93012916 P1476 "Validated animal models for antiseizure drug (ASD) discovery: Advantages and potential pitfalls in ASD screening" @default.
- Q93012916 P2093 "H Steve White" @default.
- Q93012916 P2093 "Melissa Barker-Haliski" @default.
- Q93012916 P304 "107750" @default.
- Q93012916 P31 Q13442814 @default.
- Q93012916 P31 Q7318358 @default.
- Q93012916 P356 "10.1016/J.NEUROPHARM.2019.107750" @default.
- Q93012916 P478 "167" @default.
- Q93012916 P577 "2019-08-27T00:00:00Z" @default.
- Q93012916 P698 "31469995" @default.